Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead

Area of Science:

• Cardiology
• Developmental Biology
• Genetics

Background:

• Hypoplastic left heart syndrome (HLHS) is a critical congenital heart disease affecting 8-25 per 100,000 neonates.
• While surgical interventions have improved survival, the underlying etiology of HLHS remains largely unknown.
• HLHS is understood to have a multifactorial origin involving complex genetic and signaling pathways.

Purpose of the Study:

• To provide a comprehensive review of the HLHS phenotype.
• To outline prenatal and postnatal risks associated with HLHS.
• To detail the signaling and molecular mechanisms implicated in HLHS pathogenesis.

Main Methods:

• Literature review of existing studies on HLHS.
• Analysis of genetic and molecular signaling cascades involved in heart development.
• Discussion of current research limitations and future directions.

Main Results:

• HLHS is characterized by underdevelopment of the left side of the heart.
• The review synthesizes current knowledge on HLHS etiology, highlighting genetic and signaling pathway involvement.
• Identified gaps in understanding and potential areas for future mechanistic studies.

Conclusions:

• A deeper understanding of HLHS etiology is essential for advancing therapeutic strategies.
• Mechanistic studies hold the potential to identify novel druggable targets for HLHS.
• Future research should focus on elucidating the complex molecular underpinnings of HLHS to develop effective treatments.